Archive for the ‘Health Debates’ Category
« Older Entries | Newer Entries »
Transparency on what doctors bill OHIP informs the health-care debate
Friday, June 28th, 2019
The public benefit that comes from greater transparency around OHIP billings is clear. It will help to inform the debate about how Ontario spends its health care dollars and whether the current payment structure overvalues some medical services at the expense of others… Are we achieving the best health care outcomes for the dollars we spend? Is there a better way? … Opening up the system to public scrutiny can only help to build a stronger health-care system for patients and doctors alike.
Tags: budget, economy, Health, ideology, mental Health
Posted in Health Debates | No Comments »
To bolster health, would basic income — not pharmacare — make more sense?
Tuesday, June 25th, 2019
… shouldn’t the priority of policy-makers be to ensure that all Canadians can afford necessities such as food and housing, not just prescription drugs? … Affordable sickness care is important, especially if you’re sick. But the way to keep people healthier longer is to ensure that they have a decent income, a roof over their heads, healthy food, a good education, a sound physical environment and sense of belonging.
Tags: economy, Health, ideology, mental Health, participation, pharmaceutical, poverty, standard of living
Posted in Health Debates | 4 Comments »
Yes, to national pharmacare – because we already paid for it
Tuesday, June 25th, 2019
We are paying, in effect, three times: through federal research grants, through disease-focused charities, and then at the pharmacy. A national pharmacare program could change this if… the cost of a drug over the life of its patent was calculated to recognize the public support its development received. Manufacturers would submit a funding history with a tentative pricing. A fair rate of return would be permitted for the life of a patent based on that information.
Tags: budget, Health, jurisdiction, mental Health, pharmaceutical
Posted in Health Debates | No Comments »
Why universal pharmacare will help get Canada’s drug costs under control — and why Big Pharma hates it
Saturday, June 22nd, 2019
It might be more accurate to say we can’t afford to go without it… The Hoskins report estimates an annual savings of about $5 billion in total drug spending once universal pharmacare is fully implemented… And it would strengthen employers’ ability to hire and properly compensate employees. Employer contributions to drug plans generally reduce worker pay.
Tags: economy, featured, Health, ideology, jurisdiction, mental Health, pharmaceutical, standard of living, tax
Posted in Health Debates | 1 Comment »
Pharmacare today, like medicare 50 years ago, makes sense
Friday, June 14th, 2019
In terms of cost overall, most experts agree that a universal, single-pay system would save money for Canadians… But a universal public program would also shift costs from individuals and employers to governments… Canadians would pay more in taxes for universal drug coverage. But this tax increase would be more than compensated for by the out-of-pocket, administrative and cost savings associated with the move to public pharmacare.
Tags: budget, economy, Health, ideology, mental Health, participation, standard of living, tax
Posted in Health Debates | 353 Comments »
New report provides the Trudeau Liberals with a blueprint for pharmacare
Friday, June 14th, 2019
There’s true pharmacare, as laid out by the advisory council chaired by Ontario’s former health minister, Eric Hoskins. Then there’s a paler version that seeks only to fill in the gaps by providing coverage for those who currently have none… Canadians already pay more for drugs than they do for doctors’ services and… drug costs are rising at an unsustainable 6.5 per cent per year. That has a big impact on both workplace plans and government drug benefits for seniors and the poor.
Tags: budget, economy, Health, ideology, jurisdiction, mental Health, participation, pharmaceutical, standard of living, tax
Posted in Health Debates | No Comments »
Universal Pharmacare Within Reach: C.D. Howe Institute
Friday, June 7th, 2019
In “Filling the Gaps: A Prescription for Universal Pharmacare,” Policy Analyst Rosalie Wyonch finds there are ways to close the gaps in prescription drug coverage and protect households from excessive costs when in acute need through the expansion of public insurance… The report investigates current prescription drug insurance in Canadian provinces, evaluates options for achieving universal coverage and estimates their cost.
Tags: budget, featured, Health, ideology, jurisdiction, mental Health, pharmaceutical, standard of living
Posted in Health Debates | No Comments »
Is beer in corner stores bad for our health?
Tuesday, June 4th, 2019
One thing that is clear from research is that the greatest impact on alcohol consumption comes from pricing policies. The cheaper alcohol is, the more people consume. Yet we don’t talk about the benefits of high taxes or floor prices. That’s why buck-a-beer policies and rhetoric should concern us much more than where products are sold.
Tags: economy, Health, ideology, jurisdiction
Posted in Health Debates | No Comments »
How Ontario’s cuts to public health will hurt our patients
Sunday, May 19th, 2019
We are a group of resident physicians – doctors training to be family physicians and specialists – in Ontario… we have been taught the importance of disease prevention as one of the most important tools to keep people well and out of hospital… If your government truly is committed to ending “hallway medicine” and providing the possibility of healthier lives, we urge you to reconsider the proposed significant budget cuts to Public Health.
Tags: budget, Health, ideology, mental Health, pharmaceutical, standard of living
Posted in Health Debates | No Comments »
Alternatives for alternative medicines
Friday, May 10th, 2019
… we propose general guiding regulatory principles for CAM products and practitioners. Our paper also provides a framework for governments to structure the regulation of complementary and alternative medicines and develop appropriate institutions, such as a CAM advisory council, to provide independent advice to governments on appropriate standards… although many question the legitimizing CAMs, their growth indicates that consumer demand for them is here to stay.
Tags: Health, ideology, jurisdiction, pharmaceutical
Posted in Health Debates | 6 Comments »
Recent Comments